Globally, synovial sarcoma remains a rare but aggressive malignancy with a 5-year survival rate of 70% to 80% and a 10-year survival rate around 50%. Tumor size, location, and surgical margins are key ...

CSHL Professor David Spector and graduate student Disha Aggarwal have tracked levels of long non-coding RNA MALAT1 over the ...

NEW YORK and LONDON, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today ...

Nearly 1 in 10 U.S. adults report having physician-diagnosed chronic head eczema, according to findings from a cross-sectional survey that were presented at the 2025 Fall Clinical Dermatology ...

Mashkhara Bhumnayra, diagnosed with cancer in 2022, successfully navigated his recovery by integrating conventional medical ...

Real-world evidence (RWE)—derived from analysis of real-world data (RWD)—has the potential to guide personalized treatment decisions. However, because of potential confounding, generating valid RWE is ...

Clinical development programs for new drugs include an array of research conducted both before and after a drug’s initial approval by the Food and Drug Administration (FDA). Post-approval clinical ...

As the world becomes more digital, clinical research is evolving. One major change is the rise of decentralized clinical ...